//
SPECT and PET in ischemic heart failure
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone
Respiratory Syncytial Virus and Associations With Cardiovascular Disease in Adults
Risk of Mortality Following Catheter Ablation of Atrial Fibrillation
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure
Heart failure with preserved ejection fraction: from mechanisms to therapies
Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review